Hong Kong Auto Components Stock News

SEHK:6963
SEHK:6963Insurance

A Look At Sunshine Insurance Group (SEHK:6963) Valuation After Annual Results And Final Dividend Proposal

Sunshine Insurance Group (SEHK:6963) just released its full year 2025 results alongside a proposed final cash dividend of RMB 0.19 per ordinary share, a pairing that gives investors fresh income and earnings context. See our latest analysis for Sunshine Insurance Group. The latest HK$3.71 share price comes after a 1-day share price return of 0.54%, with the dividend and earnings announcement likely shaping how investors view Sunshine Insurance Group's risk and income profile. Despite a 30-day...
SEHK:2377
SEHK:2377Commercial Services

China Boqi Environmental (SEHK:2377) Margin Improvement Challenges Long‑Term Earnings Drift Narrative

China Boqi Environmental (Holding) (SEHK:2377) has posted its FY 2025 first half numbers with revenue of C¥1,058.5 million and basic EPS of C¥0.166, against trailing twelve month revenue of C¥2,260.0 million and EPS of C¥0.285 that sit alongside a 20.6% uplift in earnings and an 11.7% net margin over the last year. The company has seen revenue move from C¥949.4 million in 1H FY 2024 to C¥1,058.5 million in 1H FY 2025, while basic EPS moved from C¥0.114 to C¥0.166 over the same halves. This...
SEHK:2567
SEHK:2567Software

Qiniu (SEHK:2567) Loss Narrows To C¥33.4m Challenging Persistent Bearish Narratives

Qiniu (SEHK:2567) has opened FY 2025 with first half revenue of C¥829.4 million and a basic EPS loss of C¥0.02 per share, alongside a net income loss of C¥33.4 million. This sets a cautious tone for investors watching the company’s path toward profitability. The company has seen first half revenue move from C¥710.4 million in FY 2024 to C¥829.4 million in FY 2025, while basic EPS shifted from a loss of C¥0.41 to a smaller loss of C¥0.02. This frames a set of results where revenue scale and...
SEHK:257
SEHK:257Commercial Services

Everbright Environment Group SEHK 257 Margin Improvement Challenges Longstanding Bearish Earnings Narrative

China Everbright Environment Group (SEHK:257) has just posted its FY 2025 first half numbers, reporting revenue of HK$14.3b and net income of HK$2.2b, equivalent to basic EPS of HK$0.36, alongside year over year earnings growth of 16.2%. The company has seen revenue move from HK$15.6b in 1H 2024 to HK$14.3b in 1H 2025 while basic EPS shifted from HK$0.40 to HK$0.36 over the same period. This sets the backdrop for a current net profit margin of 14.3% compared with 11.2% a year earlier. For...
SEHK:580
SEHK:580Electrical

EPS Momentum At Sun.King Technology Group (SEHK:580) Tests Bearish Margin And Valuation Narratives

Sun.King Technology Group (SEHK:580) has reported FY 2025 first half revenue of C¥888.3 million and basic EPS of C¥0.058, with trailing 12 month revenue at about C¥2.3 billion and basic EPS of C¥0.086 alongside a 34.5% earnings gain over the past year and earnings forecast to grow around 32.1% per year. The company has seen revenue move from C¥655.8 million and basic EPS of C¥0.021 in 1H FY 2024 to C¥954.5 million and C¥0.043 in 2H FY 2024, and then to C¥888.3 million and C¥0.058 in 1H FY...
SEHK:2886
SEHK:2886Gas Utilities

Binhai Investment (SEHK:2886) EPS Rebound To HK$0.13 Tests Bearish Earnings Narratives

Binhai Investment (SEHK:2886) has put fresh FY 2025 numbers on the table, reporting first half revenue of HK$2,931.1 million and basic EPS of HK$0.13, alongside trailing 12 month revenue of HK$5,606.4 million and EPS of HK$0.15. These results sit against a backdrop of earnings that grew 3.2% over the last year but declined on average 17.2% per year over five years. Over the past few reporting periods, revenue has moved from HK$3,530.4 million in 1H FY 2024 to HK$2,702.6 million in 2H FY 2024...
SEHK:3613
SEHK:3613Pharmaceuticals

Beijing Tong Ren Tang Chinese Medicine (SEHK:3613) Margin Compression Challenges Bullish Quality Narrative

How Beijing Tong Ren Tang Chinese Medicine's FY 2025 Numbers Set Up the Next Chapter Beijing Tong Ren Tang Chinese Medicine (SEHK:3613) has just posted FY 2025 first half numbers, with revenue of HK$761.7 million and basic EPS of HK$0.28, setting the tone for how investors will read the rest of the year. Over the last three reported halves, revenue has moved from HK$664.5 million in 1H 2024 to HK$947.1 million in 2H 2024 and now HK$761.7 million in 1H 2025, while basic EPS has tracked...
SEHK:570
SEHK:570Pharmaceuticals

China Traditional Chinese Medicine (SEHK:570) Half Year Loss Challenges Turnaround Narrative

China Traditional Chinese Medicine Holdings (SEHK:570) has reported its FY 2025 first half results with revenue of C¥7.5b and a basic EPS loss of C¥0.02, while the trailing twelve months show revenue of C¥14.7b and a basic EPS loss of C¥0.07. Over recent half year periods, revenue has moved from C¥8.4b with EPS of C¥0.04 in 1H 2024 to C¥8.1b with an EPS loss of C¥0.03 in 2H 2024, then to C¥7.5b with an EPS loss of C¥0.02 in 1H 2025, setting up a story where investors are weighing weaker...
SEHK:2282
SEHK:2282Hospitality

MGM China Holdings (SEHK:2282) Margin Stability Tests Bullish Growth Narratives

Earnings snapshot and recent momentum MGM China Holdings (SEHK:2282) has put fresh numbers on the board for FY 2025, with first half revenue of about HK$16.7b, basic EPS of HK$0.63 and net income of HK$2.4b setting the tone for the year. The business has seen revenue move from roughly HK$16.2b in 1H 2024 to HK$15.2b in 2H 2024 and then to HK$16.7b in 1H 2025, while basic EPS shifted from HK$0.71 to HK$0.50 and then HK$0.63 over the same periods. This gives a clear sense of how headline growth...
SEHK:6862
SEHK:6862Hospitality

Haidilao’s World’s Strongest Brand Title Versus Its Tougher Share Record

Haidilao International Holding has been named the World’s Strongest Restaurant Brand for 2024. The recognition highlights the company’s brand strength beyond its usual financial headlines. The stock, traded under ticker SEHK:6862, last closed at HK$15.85. For investors tracking SEHK:6862, this brand accolade arrives after a mixed share price record. The stock is up 10.0% year to date, while the 1 year return stands at a 2.6% decline and the 5 year return at a 64.6% decline, with the current...
SEHK:9660
SEHK:9660Software

Horizon Robotics (SEHK:9660) Heavy C¥5.2b Loss Tests Bullish Profitability Narratives

Horizon Robotics (SEHK:9660) has reported FY 2025 first half results with revenue of C¥1.6b and a basic EPS loss of C¥0.42, setting a clear focus on how growth is feeding through to the bottom line. The company has seen revenue move from C¥934.6m in 1H 2024 to C¥1.4b in 2H 2024 and C¥1.6b in 1H 2025, while EPS has swung from a loss of C¥1.81 in 1H 2024 to a profit of C¥1.17 in 2H 2024 before reverting to a loss, so investors are watching how quickly these top line gains can translate into...
SEHK:867
SEHK:867Pharmaceuticals

China Medical System Wins Desidustat Approval Raising Nephrology Growth Questions

China Medical System Holdings (SEHK:867) has received marketing approval in China for Desidustat Tablets, an oral treatment for renal anaemia in non dialysis chronic kidney disease patients. The approval adds a new drug to the company’s nephrology portfolio and targets a major unmet medical need in China. China Medical System Holdings is drawing fresh attention after this new approval, with the share price at HK$13.49 and a 1 year return of 81.4%. The stock has also seen a 6.1% gain over...
SEHK:6060
SEHK:6060Insurance

ZhongAn Online P & C Insurance (SEHK:6060) Net Income Surge Tests Bearish Margin Narratives

ZhongAn Online P & C Insurance (SEHK:6060) has just posted its FY 2025 first half numbers, with revenue of C¥15.8 billion and basic EPS of C¥0.45, set against trailing twelve month revenue of C¥36.4 billion and EPS of C¥0.70 that reflect the 82.5% earnings growth reported over the past year. The company has seen revenue move from C¥33.7 billion on a trailing basis in mid 2024 to C¥36.4 billion now, while EPS on the same basis has gone from C¥0.41 to C¥0.70, pointing to tighter earnings power...
SEHK:1919
SEHK:1919Shipping

COSCO Shipping Holdings (SEHK:1919) Margin Worsening Reinforces Bearish Earnings Narrative

COSCO SHIPPING Holdings (SEHK:1919) has wrapped up FY 2025 with fourth quarter revenue of C¥51.9b and basic EPS of C¥0.25. Trailing twelve month revenue came in at C¥219.5b with basic EPS of C¥1.99. Over the past few quarters, revenue has moved from C¥73.5b in Q3 2024 to C¥59.1b in Q4 2024 and then to C¥58.0b in Q1 2025 before landing at C¥51.9b in Q4 2025. Quarterly EPS shifted from C¥1.33 to C¥0.70 to C¥0.74 and then C¥0.25. With trailing net margin easing from 21% to 14.1%, the latest...
SEHK:836
SEHK:836Renewable Energy

China Resources Power Holdings (SEHK:836) Net Margin At 14.2% Tests Bearish Cash Flow Concerns

China Resources Power Holdings (SEHK:836) has just posted its FY 2025 results, with second half revenue of HK$51.7b, basic EPS of HK$1.28 and trailing twelve month EPS of HK$2.80 providing a clear snapshot of its recent earnings profile. Over the past few periods the company has seen half year revenue move from HK$54.2b in the second half of 2024 to HK$50.3b in the first half of 2025 and HK$51.7b in the second half of 2025, alongside basic EPS readings of HK$1.03, HK$1.52 and HK$1.28...
SEHK:338
SEHK:338Chemicals

Sinopec Shanghai Petrochemical (SEHK:338) Q4 TTM Loss Of C¥1.4b Reinforces Bearish Narratives

Sinopec Shanghai Petrochemical (SEHK:338) closed FY 2025 with fourth quarter revenue of C¥16.7b and a basic EPS loss of C¥0.094801 per share, alongside net income excluding extra items of a C¥1.0b loss. This puts profitability under pressure at the current share price of HK$1.37. Over recent periods, the company has seen quarterly revenue move from C¥21.1b in Q4 2024 to C¥16.7b in Q4 2025, while quarterly EPS shifted from a C¥0.03468 profit to a C¥0.094801 loss. This may lead investors to...
SEHK:1199
SEHK:1199Infrastructure

COSCO SHIPPING Ports (SEHK:1199) Margin Squeeze Challenges Bullish Efficiency Narratives

COSCO SHIPPING Ports (SEHK:1199) has wrapped up FY 2025 with fourth quarter revenue of US$434.3 million and basic EPS of US$0.012, while trailing 12 month revenue came in at about US$1.7 billion with EPS of US$0.081. Over recent periods, revenue has moved from US$394.2 million in Q4 2024 to US$434.3 million in Q4 2025. Quarterly EPS ranged between US$0.022 and US$0.026 earlier in FY 2025 before the latest print, setting the scene for investors to focus on how these earnings are converting...
SEHK:1033
SEHK:1033Energy Services

Sinopec Oilfield Service (SEHK:1033) Q4 Loss And 0.8% Margin Test Bullish Growth Narratives

Sinopec Oilfield Service (SEHK:1033) has released its FY 2025 numbers with fourth quarter revenue of about C¥25.5b and a small loss, as Basic EPS slipped to C¥0.000573, compared with C¥25.6b of revenue and Basic EPS of C¥0.002278 in the same quarter a year earlier. Over recent periods the company has seen quarterly revenue move from roughly C¥18.1b in Q3 2024 to C¥18.1b in Q3 2025 and EPS shift from C¥0.012 to C¥0.009076, while trailing twelve month EPS sits at C¥0.035 on revenue of about...
SEHK:9863
SEHK:9863Auto

Leapmotor (SEHK:9863) Profit Turnaround Tests Bullish Growth Narratives After FY 2025 Earnings

Zhejiang Leapmotor Technology (SEHK:9863) has reported its FY 2025 results with second half revenue of C¥40.5b and basic EPS of C¥0.36, alongside net income of C¥505.4m that extends a trailing twelve month net profit of C¥538.4m and basic EPS of C¥0.39. The company has seen revenue move from C¥23.3b and basic EPS of C¥0.02 in the first half of 2025, from C¥23.3b and a basic EPS loss of C¥0.46 in the second half of 2024. Trailing twelve month figures show revenue at C¥64.7b and a shift from a...
SEHK:1828
SEHK:1828Insurance

FWD Group Holdings (SEHK:1828) Net Margin Shift To 5.3% Tests High Growth Narrative

FWD Group Holdings (SEHK:1828) has just posted its FY 2025 first half scorecard, with revenue of about US$1.5 billion and basic EPS of US$0.05. This helps set the tone for how investors may interpret the company’s sharp earnings reset over the past year. The company reported revenue of US$1.3 billion in 2H 2024 and US$1.6 billion in 1H 2024 before this latest half, while basic EPS moved from US$0.0032 in 1H 2024 and US$0.0223 in 2H 2024 to US$0.05. This progression puts a clear spotlight on...
SEHK:1606
SEHK:1606Diversified Financial

A Look At China Development Bank Financial Leasing’s Valuation After Recent Share Price Moves

Recent share performance and valuation context China Development Bank Financial Leasing (SEHK:1606) has drawn investor attention after a recent 1.4% daily gain, contrasting with a month return of about 4.5% decline and a past 3 months slide of roughly 11.4%. At a last close of HK$1.48 and an estimated intrinsic discount of about 75%, the leasing group, which generates CN¥16,166.205 in revenue and CN¥5,022.752 in net income, now screens as a higher value score name. See our latest analysis for...
SEHK:6963
SEHK:6963Insurance

Sunshine Insurance Group SEHK 6963 EPS Rebound to C¥0.29 Tests Cautious Growth Narratives

Sunshine Insurance Group (SEHK:6963) opened FY 2025 with first half revenue of C¥38.5b and basic EPS of C¥0.29, against trailing 12 month revenue of C¥79.5b and EPS of C¥0.55, setting a clear earnings season marker for investors watching the stock at C¥3.63. Over the past few reporting periods, revenue has moved from C¥38.3b in the first half of 2024 to C¥40.3b in the second half of 2024 and C¥38.5b in the first half of 2025. Basic EPS shifted from C¥0.27 to C¥0.20 and then to C¥0.29, giving...
SEHK:1882
SEHK:1882Machinery

Haitian International Holdings FY 2025 EPS Beat Challenges Cautious Market Narratives

Haitian International Holdings (SEHK:1882) just reported its FY 2025 first half with revenue of C¥9.0b and basic EPS of C¥1.07, setting the tone against a trailing twelve month picture that includes C¥17.7b in revenue and EPS of C¥2.07. The company has seen revenue move from C¥8.0b in the first half of 2024 to C¥9.0b in the first half of 2025, while basic EPS has gone from C¥0.95 to C¥1.07 over the same period, all against a trailing net profit margin of 18.6% that leaves investors focused on...
SEHK:1548
SEHK:1548Life Sciences

Genscript’s 2025 Profit Swing And mRNA Expansion Might Change The Case For Investing In Genscript Biotech (SEHK:1548)

Genscript Biotech has reported its full-year 2025 results, with sales rising to US$959.53 million while the company moved from a prior-year net income of US$2.96 billion to a net loss of US$532.83 million, alongside higher basic and diluted losses per share. A key driver of this sharp swing in reported profitability is the absence of the previous year’s very large one-time unrealised gain from deconsolidation, which means the latest figures chiefly reflect the underlying operating profile...